Will ich der Vollständigkeit halber noch einfügen. Aber Herr Bronco, Doc B. und andere haben sich schon vor Jahren mit der Nanotechnologie auseinandergesetzt. Wenn dann so ein Glücksfall und die Rallye da ist, heisst es zugreifen, schliesslich hat man Jahre in die Ecke geschielt. George B. hat Mitte Dezember 2003 3,6 Milliarden locker gemacht für die Nanos, das war halt das Signal.
Gruss E.
http://chart.bigcharts.com/bc3/quickchart/...92&mocktick=1&rand=9726"
New Equipment for Production of Nanoparticles, Microfluidizer Processor Line, and Recent Enhancements Featured in Interview with MFIC CEO, Irwin Gruverman
NEWTON, Mass., Dec 1, 2003 (BUSINESS WIRE) -- At the request of CEOCFOinterviews.com, Irwin Gruverman, CEO and Chairman of MFIC Corporation ("MFIC" or the "Company") was interviewed by Walter Banks on the subject of MFIC's line of Microfluidizer(R) materials processing equipment, recent enhancements to this line, the introduction of a value priced high throughput production model, and its new, patented, Multiple Stream Mixer Reactor device for creation of nanoparticles and nanomaterials ("MMR").
MFIC provides leading edge high performance mixing and formulation equipment available to the biotech, pharmaceuticals, coatings, paint, chemical and food industries.
The full interview can be found at the Company's website: www.mficcorp.com and serves to familiarize investors with MFIC, furnishing them insight into the Company's background, performance, prospects and products while also providing an update to the October, 2002 interview with the same publisher. The in-depth interviews conducted by CEOCFOinterviews are geared toward sophisticated investors who require unbiased, unscripted first-hand perspective to assist them in making informed investment decisions.
Mr. Gruverman discussed MFIC's Microfluidizer high performance materials processing equipment, operating at the highest available pressures for high shear processing of fluids. The uniform, submicron structures created allow preparation of commercial products having unmatched uniformity, stability and reliability. Examples include injectable emulsions, ink-jet inks, finish paints, and soft drinks. In addition, Microfluidizer processors are the standard means of cell disruption for recovery of proteins produced by biotechnology processes and are widely used in genomics applications. He also discussed and elaborated upon the recently introduced MMR for continuous chemical reaction in an ultraturbulent environment, and emphasized the ability of MMR to efficiently create production quantities of nanoparticles. This ability will enable the large-scale applications of these valuable materials. MMR's impact on MFIC's growth and profitability could be large.
Mr. Gruverman discussed the recent introduction of product enhancements and features including:
-- M700 Microfluidizer Containment System, which is utilized for
the processing of highly toxic cancer drugs and other
hazardous materials. The first such recently installed system
is now producing pharmaceutical product.
-- M700 Microfluidizer Split System (separating the power source
from the mixing/processing apparatus) accommodates demands of
limited space within clean rooms and for noise abatement
within pharmaceutical production facilities. In conjunction
with this system, a Level II Steam Sterility Option was
introduced for fitting to systems used for production of
injectable and other pharmaceuticals. This option enables
compliance with stringent regulatory production requirements.
We have recently delivered such a system to a pharmaceutical
manufacturer.
-- Ultra Clean in Place (UCIP) option, which improves the ability
to clean in place (CIP) Microfluidizer systems between product
batch runs or before storage. This capability differentiates
our Microfluidizer materials processor systems from all other
competitive products. Several pilot and production systems
incorporating this option have already been delivered.
Mr. Gruverman also discussed the price and competitive advantages of the M710, MFIC's newest high throughput production system. This system is designed to materially enhance our competitive position in terms of pricing and performance in all industries and applications that we serve. In addition to biotechnology and pharmaceutical production, this product targets markets such as foods, chemicals and personal care products, by offering pricing that is more competitive with traditional homogenizers, along with MFIC's superior fluid processing technology. The M710 systems will improve our margins and delivery times significantly. More than twelve sales quotations for these systems have already been made to existing and prospective customers.
Mr. Gruverman also extensively discussed MFIC's patented Multiple Stream Mixer-Reactor (MMR) system which functions as a continuous chemical reactor. MFIC believes that MMR technology enables a new unit operation in chemical engineering practice. The device allows chemical reactions to occur under ultraturbulent mixing conditions, with no premixing. Such operations are also known as Collision Reaction Processing. These systems can be configured for continuous production of nanoparticles. MFIC is proceeding with projects involving other companies seeking to optimize or enable drug delivery, catalysts and coatings products, as well as an internal program on nanopolymer creation for drug delivery and other applications. MFIC expects to deliver the first MMR laboratory development systems (in the $200,000-$250,000 sales price range) in 2004, with production systems (in the $750,000 - $1,000,000 plus sales price range) in late 2004 or 2005. The Company believes that it is a leader in the technology of systems for continuous production of uniform, reproducible, microparticles, nanoparticles and nanodroplets.
Marketing and sales are centralized and a strong core team leads an extensive network of agents and distributors in North America, Europe and Asia. About 75% of Microfluidizer system sales are to the pharmaceutical and biotech industries. Most sales are to Fortune 500 companies.
Management believes that this release contains forward-looking statements that are subject to certain risks and uncertainties including statements relating to the Company's plan to maintain and/or increase operating profitability. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results achieved by the Company to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that the actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including but not limited to, the following risks and uncertainties: (i) whether the performance advantages of the Company's Microfluidizer(R) materials processing equipment will be realized commercially or that a commercial market for the equipment will continue to develop, (ii) whether the Company will have access to sufficient working capital through continued and improving cash flow from sales and ongoing borrowing availability, the latter being subject to the Company's ability to comply with the covenants and terms of the Company's loan agreement with its senior lender, (iii) whether the Company's expectation that the benefits of nanotechnology will, in part, be realized by the ability of the MMR to produce innovative materials in large quantities, and (iv) whether the Company's is able to increase the number of prototype MMR placements and then manufacture and introduce commercial production MMR equipment.
MFIC CORPORATION
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary, high performance Microfluidizer(R) materials processing equipment to the chemical, pharmaceutical, biotechnology, cosmetic/personal care, and food processing industries. Through its divisions, the Company provides leading equipment, and innovative technology and solutions to the chemicals, paints, pigments and coatings industries for milling, deagglomeration and dissolving. The combined resources and capabilities of the Company's equipment lines are used to provide comprehensive solutions for materials processing.
SOURCE: MFIC Corporation
|